Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Equine Veterinary Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.2042-3306.2011.00390.xPMID 21895749PMCID PMC3939654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker.

  2011cited by this paper
• BPV-1 infection is not confined to the dermis but also involves the epidermis of equine sarcoids.

  2011cited by this paper
• Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes.

  2009cited by this paper
• Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain.

  2009cited by this paper
• Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1.

  2008influential reference
• HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

  2008cited by this paper
• Bovine papillomaviruses, papillomas and cancer in cattle.

  2008cited by this paper
• Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.

  2008cited by this paper
• Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles.

  2008influential reference
• A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid protein.

  2008cited by this paper
• Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.

  2007cited by this paper
• Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions.

  2007cited by this paper
• Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

  2007cited by this paper
• [Prevalence of hereditary diseases in three-year-old Swiss Warmblood horses].

  2007influential reference
• Bovine papillomavirus: old system, new lessons?

  2006cited by this paper
• Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

  2005cited by this paper
• DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing

  2005cited by this paper
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

  2005influential reference
• Aluminium compounds for use in vaccines

  2004cited by this paper
• Efficient Intracellular Assembly of Papillomaviral Vectors

  2004cited by this paper
• Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

  2004influential reference
• On natural and artificial vaccinations.

  2003cited by this paper
• Association of bovine papillomavirus with the equine sarcoid.

  2003cited by this paper
• Evasion of host immunity directed by papillomavirus-encoded proteins.

  2002cited by this paper
• The effect of aging on immune responses.

  2002cited by this paper
• Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States.

  2001cited by this paper
• Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

  1996cited by this paper
• Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

  1996cited by this paper
• Papillomavirus-like particles for serology and vaccine development.

  1996cited by this paper
• Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

  1995influential reference
• Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

  1995cited by this paper
• Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles

  1993influential reference
• Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins

  1993influential reference
• Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles

  1993cited by this paper
• Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

  1992cited by this paper
• BCG treatment of periocular sarcoid.

  1985cited by this paper
• Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells.

  1981cited by this paper
• Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA

  1980cited by this paper
• Intracranial fibroblastic neoplasms in the hamster from bovine papilloma virus.

  1972cited by this paper
• Transmission of equine sarcoid.

  1969cited by this paper
• Transmission of equine sarcoid.

  1969cited by this paper

• Papillomavirus infection in equids

  2025cites this paper
• Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines

  2023cites this paper
• Papillomavirus-like Particles in Equine Medicine

  2023cites this paper
• Development of modern immunization agent against bovine papillomavirus type 1 infection based on BPV1 L1 recombinant protein

  2023cites this paper
• Management of equine sarcoids.

  2022cites this paper
• Aplicação intratumoral de cisplatina no tratamento de sarcóide periocular em equino

  2022cites this paper
• A comprehensive review and meta-analysis of recent advances in biotechnology for plant virus research and significant accomplishments in human health and the pharmaceutical industry

  2022cites this paper
• Papillomaviruses in equids: A decade of discovery and more to come?

  2021cites this paper
• Screening for bovine papillomavirus type 13 (BPV13) in a European population of sarcoid‐bearing equids

  2021cites this paper
• Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids

  2021cites this paper
• The Development of Novel Primer Sets to Specifically Amplify Each of the Five Different Deltapapillomaviruses That Cause Neoplasia after Cross-Species Infection

  2021cites this paper
• EQUINE SARCOIDS IN CAPTIVE WILD EQUIDS: DIAGNOSTIC AND CLINICAL MANAGEMENT OF 16 CASES—A POSSIBLE PREDISPOSITION OF THE EUROPEAN COHORT OF SOMALI WILD ASS (EQUUS AFRICANUS SOMALIENSIS)?

  2021cites this paper
• Equine Sarcoids—Causes, Molecular Changes, and Clinicopathologic Features: A Review

  2021cites this paper
• Diseases of the Skin

  2020cites this paper
• Anogenital-Associated Papillomaviruses in Animals: Focusing on Bos taurus Papillomaviruses

  2020cites this paper
• The Equine Sarcoid: Why Are There so Many Treatment Options?

  2019cites this paper
• Prophylactic Vaccination Against Papillomavirus-Induced Tumour Disease

  2017cites this paper
• Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.

  2017cites this paper
• Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine.

  2017cites this paper
• Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.

  2017cites this paper
• Potential of a BPV 1 L 1 VLP vaccine to prevent BPV 1-or BPV 2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV 2 L 1 VLPs in horse

  2017cites this paper
• Bovine Papillomavirus: New Insights into an Old Disease.

  2016cites this paper
• Laser surgery as a treatment for histologically confirmed sarcoids in the horse.

  2016cites this paper
• Immune response to bovine papillomavirus type 1 in equine sarcoid.

  2016cites this paper
• Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.

  2015cites this paper
• FREQUÊNCIA DE NEOPLASIAS CUTÂNEAS EM EQUINOS: ESTUDO RETROSPECTIVO DO LABORATÓRIO DE PATOLOGIA VETERINÁRIA DA UNIVERSIDADE FEDERAL DO PARANÁ

  2014cites this paper
• Bovine papillomavirus: opening new trends for comparative pathology

  2014cites this paper
• Protein production using the baculovirus‐insect cell expression system

  2014cites this paper
• Bovine and Human Papillomaviruses

  2014cites this paper
• Das Sarkoid als häufigster Hauttumor bei Pferden und Pferdeartigen

  2014cites this paper
• Virus-Like Particles: A future candidate vaccine in livestock and poultry

  2013cites this paper
• Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

  2013cites this paper
• Multiple evolutionary origins of bat papillomaviruses.

  2013cites this paper
• Virus-like particles: The new frontier of vaccines for animal viral infections

  2012cites this paper
• Virus-like particle-based vaccines for animal viral infections

  2012cites this paper
• Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

  2012cites this paper
• Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.

  2011cites this paper